Brain Imaging Modalities Market Size, Share & Trends Analysis Report By Imaging Type (Computed Tomography (CT), Positron Emission Tomography (PET), Magnetic Resonance Imaging (MRI), Single Photon Emission Computed Tomography (SPECT)), By Patient Type (Adults, Pediatrics, Infants), By End-User (Hospitals, Diagnostic Centers, Research Institutes) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Brain Imaging Modalities Market Size

The global brain imaging modalities market size was valued at USD 14.63 billion in 2025 and is projected to grow from USD 15.47 billion in 2026 to USD 24.12 billion by 2034, registering a CAGR of 5.71% during the forecast period from 2026 to 2034. North America dominated the brain imaging modalities market with a market share of 38.6% in 2025.

In recent years, the growth of the brain imaging modalities market has been driven by the surging cases of neurological diseases like Alzheimer’s disease, Parkinson's disease, stroke, etc., globally, which increases the demand for imaging solutions as early diagnosis is the key to disease prevention and treatment. Furthermore, the incorporation of advanced technologies like AI and ML in these imaging modalities is estimated to create opportunities for the global market growth.

Brain imaging modalities are the various techniques utilized to visualize and analyze the structure and function of the brain. These techniques are broadly bifurcated into two categories: structural imaging and functional imaging. Structural imaging is used to visualize brain anatomy and diagnose gross injuries and intracranial diseases. CT, MRI, and PET are some of the most common structural imaging modalities used. CT utilizes X-rays to create detailed images of the brain's structure, whereas MRI uses magnetic fields and radio waves to generate high-resolution images of the brain's anatomy.

PET, on the other hand, detects metabolic activity in the brain by injecting a small amount of radioactive tracer into the patient's bloodstream. Functional imaging is used to assess brain activity and function. Common functional imaging modalities include functional MRI (fMRI), electroencephalography (EEG), magnetoencephalography (MEG), and near-infrared spectroscopy (NIRS). fMRI measures brain activity by detecting changes in blood flow and oxygenation, whereas EEG and MEG measure electrical activity. In contrast, NIRS measures brain activity by detecting changes in the concentrations of oxygenated and deoxygenated hemoglobin in the blood.

Imaging Type Insights

The market is segmented into Computed Tomography (CT), Positron Emission Tomography (PET), Magnetic Resonance Imaging (MRI), and Single Photon Emission Computed Tomography (SPECT). Magnetic Resonance Imaging (MRI) will dominate the market during the forecast period. Several factors can be credited to the fact that magnetic resonance imaging (MRI) is the dominant modality in the market for brain imaging. In the first place, magnetic resonance imaging (MRI) is able to produce high-resolution images of the brain, which enables precise diagnosis and monitoring of neurological conditions. To begin, magnetic resonance imaging (MRI) is a non-invasive imaging technique, which means that it does not use radiation like computed tomography (CT) scans do. This makes it a safer option for patients. Thirdly, magnetic resonance imaging (MRI) has a wide range of applications in the field of neurology, including the diagnosis and monitoring of neurological conditions such as dementia, heart disease, multiple sclerosis, stroke, and brain tumors.

Request Customizationto receive a tailored report.

Patient Type Insights

The market is segmented into adults, pediatrics, and infants. The adult segment is estimated to own the market over the forecast period. This dominance is established by the higher prevalence of neurological conditions and increased demand for brain imaging services among adults. Adults frequently require brain imaging modalities for the diagnosis and monitoring of a variety of neurological disorders, including brain tumors, stroke, dementia, and other conditions that are more common in the adult population. The Adult segment's dominance in the brain imaging modalities market is reinforced by the larger patient population in this category, which results in a higher volume of brain imaging procedures performed on adults than on pediatrics and infants. Furthermore, adults frequently present with a broader range of neurological conditions, necessitating the use of brain imaging modalities for accurate diagnosis and treatment.

End-Users Insights

The market is bifurcated into hospitals, diagnostic centers, and research institutes. The hospitals segment held the largest market share throughout the forecast period. This dominance is based on hospitals' central role in providing healthcare services, such as diagnostic imaging for neurological conditions. Hospitals are outfitted with advanced imaging technologies such as MRI, CT, PET, and SPECT, which enable comprehensive brain imaging services for patients requiring neurological assessments and treatments. Hospitals are primary care facilities where patients receive various medical services, including diagnostic imaging for neurological disorders. The availability of brain imaging modalities in hospitals allows for timely and accurate diagnosis of brain-related conditions, resulting in appropriate treatment plans and patient care. Furthermore, hospitals frequently have specialized departments and neuroimaging centers dedicated to brain imaging research, highlighting their market importance.

Speak to an Analystto discuss market opportunities.

Regional Analysis

North America dominates the global brain imaging modalities market, primarily driven by the United States and Canada. The region's leadership is attributed to several factors, including advanced healthcare infrastructure, substantial healthcare expenditure, and extensive research activities. The U.S. healthcare system is characterized by its robust investment in medical technology and innovation. According to the American Hospital Association, U.S. hospitals spend over $300 billion annually on medical technology, including state-of-the-art imaging equipment. This substantial investment enables the adoption of cutting-edge imaging technologies, like functional Magnetic Resonance Imaging (fMRI), Positron Emission Tomography (PET), and Magnetoencephalography (MEG).

Moreover, the high prevalence of neurological disorders in North America necessitates advanced diagnostic tools. The Alzheimer's Association reports that more than 6 million Americans live with Alzheimer's disease, and this number is expected to rise as the population ages. The increasing incidence of other neurological conditions, such as Parkinson's disease and epilepsy, further drives the demand for sophisticated brain imaging modalities. The region's focus on early diagnosis and effective management of these disorders underscores the need for advanced imaging techniques.

Additionally, North America benefits from strong support for research and development (R&D) in the medical field. The presence of leading research institutions and collaboration between academia and industry fosters innovation in brain imaging technologies. Government initiatives and funding, such as those from the National Institutes of Health (NIH), play a crucial role in advancing research and improving diagnostic capabilities. The integration of artificial intelligence (AI) in imaging systems is another significant driver in the region. North American companies are at the forefront of developing AI-powered imaging solutions that enhance diagnostic accuracy and efficiency. Thus, the combination of advanced healthcare infrastructure, significant investment in technology, high prevalence of neurological disorders, and strong R&D support positions North America as a dominant player in the global brain imaging modalities industry.

Unlock Regional Insightsto access country-level data, & regional trends.

Asia Pacific Brain Imaging Modalities Market Trends

The Asia Pacific region is poised for significant growth in the market, driven by increasing healthcare investments and rising awareness of neurological disorders. Countries like China and India are at the forefront due to their large populations and improving healthcare infrastructure. The rapid urbanization and economic development in these countries are leading to higher disposable incomes, enabling more people to access advanced medical technologies. Additionally, government initiatives to enhance healthcare services and promote early diagnosis of diseases are boosting the demand for brain imaging modalities. Furthermore, the rising prevalence of neurological disorders, coupled with increasing investments in research and development, propels the adoption of brain imaging technologies in this dynamic region.

List of Key and Emerging Players in Brain Imaging Modalities Market